• About Us
  • Contact Us
  • Email Whitelisting
  • Terms and Conditions
  • Privacy Policy
Wholesome Area - Beauty Secrets and Tips
No Result
View All Result
  • Health Care
  • Health News
  • Healthy Advices
  • Well Being
  • Health Care
  • Health News
  • Healthy Advices
  • Well Being
No Result
View All Result
Wholesome Area - Beauty Secrets and Tips
No Result
View All Result
Home Health Care

New antibiotic could treat drug-resistant gonorrhea, study says

by
April 14, 2025
in Health Care
0
New antibiotic could treat drug-resistant gonorrhea, study says
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

A new class of antibiotic has been found to be safe and effective in treating gonorrhea in late-stage trials, according to a new study published Monday in The Lancet. 

The drug, called gepotidacin, works by preventing bacteria from replicating in the body and was approved by the Food and Drug Administration in March to treat uncomplicated urinary tract infections in women and in girls 12 years and older.  

If approved to treat gonorrhea, it will be the newest antibiotic to treat the sexually transmitted infection since the 1990s.  

The drug is manufactured by the pharmaceutical company GSK and is sold under the name Blujepa.  

After reaching a historic low in 2009, cases of gonorrhea in the United States steadily increased until 2021 and have slowly declined since then, according to the Centers for Disease Control and Prevention (CDC).  

Still, gonorrhea is the second most common sexually transmitted infection in the country with 601,319 reported cases in 2023, according to the agency.  

Gonorrhea, and other STIs, are becoming more difficult to treat as they become increasingly more resistant to existing antibiotics. 

The CDC currently recommends providers treat gonorrhea with a 500 mg injection of the antibiotic ceftriaxone. The agency updated its treatment guidelines in 2023, directing providers to administer a higher dose of the drug to combat antibiotic resistance. 

Justin Gill, an urgent care nurse practitioner and president of the Washington State Nurses Association, told The Hill that he frequently treats gonorrhea and has encountered cases of the infection that are resistant to ceftriaxone.  

“There are only a handful of antibiotics that are available as backup options,” he said. “The development of new antibiotics has been slow, but federal investment in new and emerging antibiotic options is necessary before resistant strains of gonorrhea expand further.”  

If left untreated, gonorrhea can cause serious health complications which can lead to infertility in both men and women, as well as increasing the odds of contracting and passing HIV, according to the CDC.  

The trial of more than 620 people showed gepotidacin was about 92 percent effective in treating the infection among those who took the drug twice a day. Meanwhile, a regimen of combination ceftriaxone and azithromycin was about 91 percent effective.  

Stuart Ray, an infectious disease professor at Johns Hopkins University School of Medicine who did not take part in the study, said that any progress in safely and effectively treating gonorrhea is “exciting.” He added that the fact that the drug can be administered in pill form makes it “attractive.”  

“In general, it’s very exciting to see a late-stage trial for a new antimicrobial for a thorny problem like gonorrhea,” he said. “I think it’s very exciting to see data and progression of an agent this far down the path.” 

Ray said that of the more than 600 trial participants, less than 10 percent were women.  

“We have to be careful about making conclusions about subgroups that may have been somewhat underrepresented.”  

Previous Post

7 US service members had ‘COVID-19-like symptoms’ after 2019 Wuhan games: Pentagon report

Next Post

White House launches national security investigation into pharma, semiconductors

Next Post
White House launches national security investigation into pharma, semiconductors

White House launches national security investigation into pharma, semiconductors

  • Trending
  • Comments
  • Latest
Americans die younger in states with conservative policies: study

Americans die younger in states with conservative policies: study

October 27, 2022
Those at risk for severe COVID-19 often least likely to get monoclonal antibodies

Those at risk for severe COVID-19 often least likely to get monoclonal antibodies

April 26, 2022
Biden says US has offered vaccines to North Korea but got no response

Biden says US has offered vaccines to North Korea but got no response

May 21, 2022
In Alzheimer’s, DNA errors stress cells, create dysfunction

In Alzheimer’s, DNA errors stress cells, create dysfunction

April 26, 2022
HHS abruptly cancels preventive services task force meeting

HHS abruptly cancels preventive services task force meeting

0
Authentic Doctors V/S Quacks: Do You Really Know the Difference?

Authentic Doctors V/S Quacks: Do You Really Know the Difference?

0
Top Picks for Meditation Location in the US for a Person with Disability

Top Picks for Meditation Location in the US for a Person with Disability

0
Treat Yourself at the Spa: 7 Health Benefits of Spa Treatments

Treat Yourself at the Spa: 7 Health Benefits of Spa Treatments

0
HHS abruptly cancels preventive services task force meeting

HHS abruptly cancels preventive services task force meeting

July 9, 2025
Two summer COVID strains – Nimbus and Stratus – less severe than earlier strains: doctor

Two summer COVID strains – Nimbus and Stratus – less severe than earlier strains: doctor

July 9, 2025
Not all brands are onboard with ditching synthetic dyes

Not all brands are onboard with ditching synthetic dyes

July 9, 2025
Trump’s CDC nominee advances on party-line vote in Senate 

Trump’s CDC nominee advances on party-line vote in Senate 

July 9, 2025

Recent News

HHS abruptly cancels preventive services task force meeting

HHS abruptly cancels preventive services task force meeting

July 9, 2025
Two summer COVID strains – Nimbus and Stratus – less severe than earlier strains: doctor

Two summer COVID strains – Nimbus and Stratus – less severe than earlier strains: doctor

July 9, 2025
Not all brands are onboard with ditching synthetic dyes

Not all brands are onboard with ditching synthetic dyes

July 9, 2025
Trump’s CDC nominee advances on party-line vote in Senate 

Trump’s CDC nominee advances on party-line vote in Senate 

July 9, 2025
Enter Your Information Below To Receive Free Health and Beauty Tips and Ideas





    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!
    • About Us
    • Contact Us
    • Email Whitelisting
    • Terms and Conditions
    • Privacy Policy
    • About Us
    • Contact Us
    • Email Whitelisting
    • Terms and Conditions
    • Privacy Policy

    Disclaimer: Wholesomearea.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized beauty advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give health advice or provide beauty recommendation. Any recommendations here should be taken into consideration only after consulting with your doctor.
    © 2025 Wholesomearea.com. All rights reserved.

    No Result
    View All Result
    • Health Care
    • Health Medicine
    • Health News
    • Healthy Advices
    • Well Being

    Disclaimer: Wholesomearea.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized beauty advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give health advice or provide beauty recommendation. Any recommendations here should be taken into consideration only after consulting with your doctor.
    © 2025 Wholesomearea.com. All rights reserved.